313 related articles for article (PubMed ID: 34791687)
1. Emerging on-chip electrokinetic based technologies for purification of circulating cancer biomarkers towards liquid biopsy: A review.
Shi L; Esfandiari L
Electrophoresis; 2022 Jan; 43(1-2):288-308. PubMed ID: 34791687
[TBL] [Abstract][Full Text] [Related]
2. Liquid Biopsy: General Concepts.
Poulet G; Massias J; Taly V
Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
[TBL] [Abstract][Full Text] [Related]
3. Advanced liquid biopsy technologies for circulating biomarker detection.
Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
[TBL] [Abstract][Full Text] [Related]
4. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
5. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy.
Marrugo-Ramírez J; Mir M; Samitier J
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248975
[TBL] [Abstract][Full Text] [Related]
6. Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects.
Kim YJ; Min J
Anal Bioanal Chem; 2024 Apr; 416(9):2065-2078. PubMed ID: 37963993
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy: A New Tool in Oncology.
Costa JL; Schmitt FC
Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
[No Abstract] [Full Text] [Related]
8. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
Kong W; Chen T; Li Y
Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
[TBL] [Abstract][Full Text] [Related]
9. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in integrated microfluidics for liquid biopsies and future directions.
Zhuang J; Xia L; Zou Z; Yin J; Lin N; Mu Y
Biosens Bioelectron; 2022 Dec; 217():114715. PubMed ID: 36174359
[TBL] [Abstract][Full Text] [Related]
11. Challenges and achievements of liquid biopsy technologies employed in early breast cancer.
Alba-Bernal A; Lavado-Valenzuela R; Domínguez-Recio ME; Jiménez-Rodriguez B; Queipo-Ortuño MI; Alba E; Comino-Méndez I
EBioMedicine; 2020 Dec; 62():103100. PubMed ID: 33161226
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy for brain tumors.
Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
[TBL] [Abstract][Full Text] [Related]
13. Opportunities and challenges of circulating biomarkers in neuroblastoma.
Trigg RM; Shaw JA; Turner SD
Open Biol; 2019 May; 9(5):190056. PubMed ID: 31088252
[TBL] [Abstract][Full Text] [Related]
14. Advancements in microfluidic technologies for isolation and early detection of circulating cancer-related biomarkers.
Rana A; Zhang Y; Esfandiari L
Analyst; 2018 Jun; 143(13):2971-2991. PubMed ID: 29790491
[TBL] [Abstract][Full Text] [Related]
15. Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer.
Sierra J; Marrugo-Ramirez J; Rodríguez-Trujillo R; Mir M; Samitier J
Sensors (Basel); 2020 Feb; 20(5):. PubMed ID: 32121271
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
17. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
[TBL] [Abstract][Full Text] [Related]
18. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.
Corvigno S; Johnson AM; Wong KK; Cho MS; Afshar-Kharghan V; Menter DG; Sood AK
Mol Cancer Ther; 2022 Jul; 21(7):1067-1075. PubMed ID: 35545008
[TBL] [Abstract][Full Text] [Related]
19. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.
Batool SM; Yekula A; Khanna P; Hsia T; Gamblin AS; Ekanayake E; Escobedo AK; You DG; Castro CM; Im H; Kilic T; Garlin MA; Skog J; Dinulescu DM; Dudley J; Agrawal N; Cheng J; Abtin F; Aberle DR; Chia D; Elashoff D; Grognan T; Krysan K; Oh SS; Strom C; Tu M; Wei F; Xian RR; Skates SJ; Zhang DY; Trinh T; Watson M; Aft R; Rawal S; Agarwal A; Kesmodel SB; Yang C; Shen C; Hochberg FH; Wong DTW; Patel AA; Papadopoulos N; Bettegowda C; Cote RJ; Srivastava S; Lee H; Carter BS; Balaj L
Cell Rep Med; 2023 Oct; 4(10):101198. PubMed ID: 37716353
[TBL] [Abstract][Full Text] [Related]
20. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
